| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.21 | 0.5 |